Auna Investor Day: Colombia Pressures Force EBITDA Growth Reset

What happened

Auna held its 2026 Investor Day outlining plans to expand its integrated healthcare platform across Latin America, but simultaneously lowered its adjusted EBITDA growth expectations for the year due to reimbursement and contracting pressures in Colombia. This reset confirms the margin conversion problem that has plagued recent quarters, where strong revenue growth has not translated into profitable growth. Colombia's increasing mix of PGP risk-sharing contracts has boosted volumes but diluted margins, and management's earlier expectation of 2H26 price adjustments now appears insufficient to offset the drag. The company reiterated its long-term growth ambitions while acknowledging near-term earnings pressure, which aligns with the WAIT rating and a cautious stance. Investors should focus on the November 18 3Q26 results to see if Mexico's improving utilization and Peru's billing normalization can compensate for Colombia's weakness.

Implication

The EBITDA reset means the margin recovery thesis is delayed and near-term catalysts have turned negative. Investor Day failed to provide a credible bridge from KPI growth to EBITDA conversion, leaving the stock exposed to further downside if 3Q26 shows no improvement in Mexico and lingering penalties in Peru. The base case of $5.80 now looks optimistic, and the bear case of $4.20 becomes more plausible unless management produces specific contractual fixes in Colombia. With leverage at 3.6x and interest coverage at 1.4x, continued EBITDA weakness could heighten balance-sheet risk. We recommend waiting for either a pullback toward $4.60 or clear signs of margin inflection before establishing a position.

Thesis delta

The EBITDA growth reset weakens the base-case assumption that margin recovery would be gradual and manageable. Colombia's reimbursement pressures were expected to be offset by 2H26 price adjustments, but the reset signals those offsets are inadequate. This shifts probability weight toward the bear scenario and raises the bar for a bullish call: we now require evidence of Mexico EBITDA inflection and leverage below 3.5x before considering an upgrade.